helicobacter pylori vaccine + helicobacter pylori vaccine + helicobacter pylori vaccine + helicobacter pylori vaccine + Placebo + helicobacter pylori vaccine + helicobacter pylori vaccine
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Helicobacter Pylori
Conditions
Helicobacter Pylori, Gastritis, Gastric Cancer, Gastroduodenal Ulcers, Lymphoma
Trial Timeline
Feb 1, 2001 → Apr 1, 2002
NCT ID
NCT00613665About helicobacter pylori vaccine + helicobacter pylori vaccine + helicobacter pylori vaccine + helicobacter pylori vaccine + Placebo + helicobacter pylori vaccine + helicobacter pylori vaccine
helicobacter pylori vaccine + helicobacter pylori vaccine + helicobacter pylori vaccine + helicobacter pylori vaccine + Placebo + helicobacter pylori vaccine + helicobacter pylori vaccine is a phase 1 stage product being developed by Novartis for Helicobacter Pylori. The current trial status is completed. This product is registered under clinical trial identifier NCT00613665. Target conditions include Helicobacter Pylori, Gastritis, Gastric Cancer.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00613665 | Phase 1 | Completed |
Competing Products
6 competing products in Helicobacter Pylori
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Ilaprazole antisecretory drug of each quadruple therapy the Ilaprazole -based quadruple therapy + Esoprazole antisecretory drug of each quadruple therapy Esoprazole-based quadruple therapy | Sun Pharmaceutical | Approved | 85 |
| Rabeprazole Sodium | Eisai | Pre-clinical | 23 |
| H.pylori vaccines + Placebo Vaccine | Novartis | Phase 1 | 33 |
| Vonoprazan + Amoxicillin + Clarithromycin + Lansoprazole | Phathom Pharmaceuticals | Phase 3 | 72 |
| pantoprazole + bismuth + metronidazole + tetracycline | Pacific Biosciences | Approved | 77 |
| RHB-105 + Active Comparator | RedHill Biopharma | Phase 3 | 69 |